Silvec Biologics, Inc.
Gaithersburg, MD
- UEI
- ZH7KBVHXP1C3
- CAGE
- 8LAV6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 200 Girard St #200, Gaithersburg, MD 20877, USA
- Website
- silvec.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Maryland, College Park | 20257002945217 | $601,573 | |
| University Of Maryland, College Park | 2330663 | $376,584 | |
| University Of Maryland, College Park | 20227002938492 | $280,095 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Soilcea | Tampa, FL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| AUM Biotech LLC | Philadelphia, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Autonomous Therapeutics Inc. | Silver Spring, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Agrospheres, Inc. | Charlottesville, VA | 562910 Remediation Services |
| Innatrix Inc. | Cary, NC | 541990 All Other Professional, Scientific, and Technical Services |
About the company
Silvec Biologics, Inc. is a biotechnology company located in Gaithersburg, Maryland, that specializes in developing innovative RNA interference (RNAi) technologies for agricultural applications. The company focuses on creating novel RNA therapies designed to protect agricultural crops against devastating bacterial, viral, and fungal pathogens through advanced gene silencing techniques. Registered in SAM.gov since April 30, 2020, Silvec Biologics operates as a for-profit corporate entity and has established itself as a pioneering research organization in the field of plant disease prevention using cutting-edge molecular technologies.
Through multiple federal grant awards from agencies like the National Science Foundation (NSF), Department of Agriculture (USDA), and Department of Energy, Silvec Biologics has consistently pursued research to develop RNA-based solutions for agricultural challenges. The company's primary work involves creating small interfering RNA (siRNA) technologies to combat specific plant diseases, including citrus greening (Huanglongbing), Xylella fastidiosa infections, grapevine red blotch virus, and various fungal diseases affecting crops like grapevines. Their research has focused on developing proprietary internally-delivered virus-like RNA (iRNA) vector systems that can generate siRNAs to silence critical pathogen genes. Notably, Silvec has worked closely with the University of Maryland as a collaborative partner, receiving sub-awards to support research into gene silencing systems. The company's grant-funded projects have typically ranged from $174,964 to $994,939, with research periods spanning one to two years, demonstrating a consistent commitment to innovative agricultural biotechnology solutions that could potentially revolutionize crop protection strategies.
Quick answers
Is Silvec Biologics, Inc. registered in SAM.gov?
Yes. Silvec Biologics, Inc.'s SAM.gov registration is active through September 2, 2027.
What is Silvec Biologics, Inc.'s most recent federal award?
Silvec Biologics, Inc.'s most recent federal grant award is Delivery of sirna-containing tetrahedral RNA nanostructures into bioenergy crops using LDH stabilized sprays (DESC0025759), from Office of Science, on February 18, 2025.
On GovTribe
See Silvec Biologics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors